Skip to main content

Cancer vaccine with minimal side effects nearing Phase 3 clinical trials

By ABC News  
   January 22, 2024

The most recent data presented at an academic conference showed nearly 95% of people given only the vaccine were still alive three years after starting treatment and 64% were still disease-free.

Full story


Get the latest on healthcare leadership in your inbox.